Caribou Biosciences (CRBU) FCF Margin (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,364.00 |
| Dec 31, 2025 | 69,378.00 |
| Sep 30, 2025 | -19,289.00 |
| Jun 30, 2025 | 58,207.00 |
| Mar 31, 2025 | 31,969.00 |
| Dec 31, 2024 | -30,128.00 |
| Sep 30, 2024 | -71,143.00 |
| Jun 30, 2024 | 67,919.00 |
| Mar 31, 2024 | -92,636.00 |
| Dec 31, 2023 | -52,312.00 |
| Sep 30, 2023 | 33,908.00 |
| Jun 30, 2023 | 36,592.00 |
| Mar 31, 2023 | -26,251.00 |
| Dec 31, 2022 | 13,420.00 |
| Sep 30, 2022 | -13,416.00 |
| Jun 30, 2022 | 25,641.00 |
| Mar 31, 2022 | 6,755.00 |
| Dec 31, 2021 | -53,789.00 |
| Sep 30, 2021 | 77,870.00 |
| Jun 30, 2021 | -242,843.00 |